Tularik
(NASDAQ: AMGN) Biotechnology company creating novel medicines that regulate gene expression. IPO in 1999; subsequently acquired by Amgen in 2004.
| URL: | http://www.tularik.com |
|---|---|
| Stock Symbol: | AMGN |
© 2008 Mayfield Fund. All rights reserved. | Privacy Statement | Terms of Use